There are 35 resources available
Welcome and introduction
Presenter: Timothy Price
Session: Takeda Pharmaceuticals - Navigating later-line treatment decisions in mCRC: Using the latest data to guide treatment selection
Resources:
Webcast
Reshaping later-line management of mCRC: Latest developments, practical implications
Presenter: Cathy Eng
Session: Takeda Pharmaceuticals - Navigating later-line treatment decisions in mCRC: Using the latest data to guide treatment selection
Resources:
Webcast
Panel discussion
Presenter: Timothy Price, Cathy Eng, Su Pin Choo
Session: Takeda Pharmaceuticals - Navigating later-line treatment decisions in mCRC: Using the latest data to guide treatment selection
Resources:
Webcast
Welcome and introduction
Presenter: Yoon-Sim Yap
Session: Novartis - Expanding evidence for CDK4/6 inhibitors in HR+/HER2- breast cancer: From clinical trials to clinical practice
Resources:
Webcast
Unmet need for patients with HR+/HER2- early breast cancer
Presenter: Yoon-Sim Yap
Session: Novartis - Expanding evidence for CDK4/6 inhibitors in HR+/HER2- breast cancer: From clinical trials to clinical practice
Resources:
Webcast
Patient selection and clinical outcomes of CDK4/6 inhibitors in HR+/HER2- early breast cancer
Presenter: Dejan Juric
Session: Novartis - Expanding evidence for CDK4/6 inhibitors in HR+/HER2- breast cancer: From clinical trials to clinical practice
Resources:
Webcast
Clinical guidance on use of CDK4/6 inhibitors in HR+/HER2- ABC
Presenter: Yoon-Sim Yap
Session: Novartis - Expanding evidence for CDK4/6 inhibitors in HR+/HER2- breast cancer: From clinical trials to clinical practice
Resources:
Webcast
Applying CDK4/6 inhibitor data to patient management in HR+/HER2- ABC
Presenter: Shusen Wang
Session: Novartis - Expanding evidence for CDK4/6 inhibitors in HR+/HER2- breast cancer: From clinical trials to clinical practice
Resources:
Webcast
Key takeaways and live Q&A
Presenter: Yoon-Sim Yap
Session: Novartis - Expanding evidence for CDK4/6 inhibitors in HR+/HER2- breast cancer: From clinical trials to clinical practice
Resources:
Webcast
Welcome and introduction
Presenter: Takayuki Yoshino
Session: Merck Healthcare KGaA - Shaping the future of mCRC: Expert dialogues on research and practice
Resources:
Webcast